GRI Bio, Inc. (GRI)

GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $3.32 million. The enterprise value is -$655,770.

Market Cap	3.32M
Enterprise Value	-655,770

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 13.94 million shares outstanding. The number of shares has increased by 2,263.41% in one year.

Current Share Class	13.94M
Shares Outstanding	13.94M
Shares Change (YoY)	+2,263.41%
Shares Change (QoQ)	+18.88%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	3.25%
Float	12.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.39
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.04.

Current Ratio	1.70
Quick Ratio	1.47
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -397.84% and return on invested capital (ROIC) is -240.01%.

Return on Equity (ROE)	-397.84%
Return on Assets (ROA)	-137.52%
Return on Invested Capital (ROIC)	-240.01%
Return on Capital Employed (ROCE)	-556.95%
Revenue Per Employee	n/a
Profits Per Employee	-$3.29M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.08% in the last 52 weeks. The beta is -1.25, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.25
52-Week Price Change	-98.08%
50-Day Moving Average	1.12
200-Day Moving Average	1.51
Relative Strength Index (RSI)	25.69
Average Volume (20 Days)	4,576,350

Short Selling Information

The latest short interest is 2.69 million, so 19.28% of the outstanding shares have been sold short.

Short Interest	2.69M
Short Previous Month	383,633
Short % of Shares Out	19.28%
Short % of Float	21.09%
Short Ratio (days to cover)	0.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.27M
Pretax Income	-11.25M
Net Income	-13.16M
EBITDA	-11.26M
EBIT	-11.27M
Earnings Per Share (EPS)	-$8.97

Balance Sheet

The company has $4.05 million in cash and $84,000 in debt, with a net cash position of $3.97 million or $0.28 per share.

Cash & Cash Equivalents	4.05M
Total Debt	84,000
Net Cash	3.97M
Net Cash Per Share	$0.28
Equity (Book Value)	1.99M
Book Value Per Share	0.61
Working Capital	1.94M

Cash Flow

Operating Cash Flow	-9.21M
Capital Expenditures	n/a
Free Cash Flow	-9.21M
FCF Per Share	-$0.66

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,263.41%
Shareholder Yield	-2,263.41%
Earnings Yield	-396.84%
FCF Yield	-277.93%

Analyst Forecast

The average price target for GRI Bio is $23.00, which is 9,567.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	9,567.93%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-71.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 1:17.

Last Split Date	Feb 24, 2025
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	1